Cardiovascular Diseases

Artificial Sweeteners Linked to CVD Risk

A French population based prospective cohort study suggests a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease (CVD) risk. The study included 103 388 participants of the web-based cohort (mean age 42.2 years, 79.8% female, 904 206 person years) from 2009 to 2021. Dietary intakes and consumption of artificial sweeteners were assessed by repeated 24 h dietary records. Total artificial sweetener intake was associated with increased risk of CVD (hazard ratio [HR] 1.09); absolute incidence rate in higher consumers (above the sex specific median) and non-consumers was 346 and 314 per 100 000 person years, respectively. Artificial sweeteners were more particularly associated with cerebrovascular disease risk (HR 1.18). Aspartame intake was associated with increased risk of cerebrovascular events (HR 1.17), and acesulfame potassium and sucralose were associated with increased coronary heart disease risk (acesulfame potassium: HR 1.40; sucralose: HR 1.31). The findings are in line with previous studies and suggest that artificial sweeteners should not be considered a healthy and safe alternative to sugar and might represent a modifiable risk factor for CVD prevention. Source: https://www.bmj.com

hyangiu

Recent Posts

Mindfulness-Based Stress Reduction on Par with Escitalopram for Anxiety Disorders

Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…

3 days ago

Key Messages of 2024 ESC Guidelines for High BP

The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…

1 month ago

CRP, LDL Cholesterol, and Lipoprotein(a) Levels Predictive of CVD

A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…

1 month ago

No Benefit to Stop Beta-Blockers After MI

A French multicenter, open label, randomized, noninferiority trial suggested that interruption of long-term beta-blocker treatment…

2 months ago

Plant vs Animal Fat on Mortality

A US prospective cohort study demonstrated that replacement of animal fat with an equivalent amount…

2 months ago

UK T2D Remission Program Findings

An ongoing UK national prospective program shows remission of type 2 diabetes (T2D) outside of…

2 months ago

This website uses cookies.